Or. Colamonici et al., INTERFERON-ALPHA (IFN-ALPHA) SIGNALING IN CELLS EXPRESSING THE VARIANT FORM OF THE TYPE-I IFN RECEPTOR, The Journal of biological chemistry, 269(8), 1994, pp. 5660-5665
Two different type I interferon receptors (IFN-R) have been described:
the normal and the variant receptors. The a subunit of the Type I IFN
-R has a molecular mass of 110 kDa in cells expressing normal and vari
ant receptors. The beta subunit has a molecular mass of approximately
100 kDa in cells that express normal receptors and 55 kDa in cells exp
ressing the variant form of the receptor. The IFN alpha-resistant U-93
7 cell line expresses variant receptors and fails to down-regulate and
phosphorylate the alpha subunit on tyrosine residues. We report that
two other myelomonocytic cell lines, YK-M2 and ML-2, also expressing t
he variant form of the receptor, fail to down-regulate and phosphoryla
te the a subunit on tyrosine residues. However, YK-M2 and ML-2 cells a
re sensitive to the antiproliferative and antiviral effects of IFN alp
ha 2, indicating that phosphorylation of the a subunit is not necessar
y to elicit an IFN alpha response and that expression of variant recep
tors is not a source of IFN alpha resistance. We also determined if ot
her proteins involved in the IFN alpha signal transduction pathway had
a different phosphorylation pattern. Treatment of cells expressing va
riant receptors induced tyrosine phosphorylation of the p135(tyk2) tyr
osine kinase, and the three interferon-stimulated gene factor 3 alpha
(ISGFS3 alpha) polypeptides (p113, p91, and p84), albeit at lower leve
ls. These results indicate that cells expressing either form of the Ty
pe I IFN-R phosphorylate a similar set of proteins, with the exception
of the alpha subunit.